ABSTRACTS

P.12 Evaluation of CD200 expression in differential diagnosis of CD5+ B cell NHLs

BJH - 2013, issue BHS Abstractbook, january 2013

B.A.P.M. Depreter , J. Emmerechts MD, PhD, B. Cauwelier MD, PhD

Read more

P.13 G8 as a screening tool for older patients with malignant haemopathies: A surrogate for CGA?

BJH - 2013, issue BHS Abstractbook, january 2013

S. Dubruille PhD, M. Maerevoet MD, R. Roos , V. Vandenbossche , N. Meuleman MD, PhD, Y. Libert PhD, D. Bron MD, PhD

Read more

P.14 Bendamustin shows distinct anti-tumoural responses in multiple myeloma patients that relapsed after prior bortezomib and lenalidomide treatment. A study on behalf of the MM BHS subcommittee

BJH - 2013, issue BHS Abstractbook, january 2013

J. Caers MD, PhD, M.C. Vekemans MD, I. Vande Broek MD, PhD, P.H. Mineur , K. Beel MD, PhD, V. Maertens MD, C. Schuermans MD, F. Leleu , G. Vanstraelen , H. Demuynck MD, W. Schroyens MD, PhD, E. Van den Neste MD, PhD, G. Bries MD, PhD, A. Van De Velde MD, PhD, M. Delforge MD, PhD, C. Doyen MD

Read more

P.15 Genomic profiling of myeloma: A comparison of cytogenetics, FISH and array- CGH analysis of 95 cases at diagnosis or follow up

BJH - 2013, issue BHS Abstractbook, january 2013

K. Rack PhD, S. Vidrequin , M. Devos , L. Dargent

Read more

P.16 Expression of TMEM45A, a candidate gene of chemoresistance, in a panel of neoplastic tissues

BJH - 2013, issue BHS Abstractbook, january 2013

C. Graux MD, PhD, L. Finet , F. George , L. D’Hondt , C. Michiels

Read more

P.17 Complete responses of the TEMPI syndrome to bortezomib

BJH - 2013, issue BHS Abstractbook, january 2013

W. Schroyens MD, PhD, Z. Berneman MD, PhD, A. Gadisseur MD, PhD, A. Van De Velde MD, PhD, I. Vrelust MD

Read more

P.18 Concurrent B-cell chronic lymphocytic leukaemia and multiple myeloma

BJH - 2013, issue BHS Abstractbook, january 2013

P. van Gaal , K. Beel MD, PhD, C. Denis , P. Zachée MD, PhD

Read more